Invest1 distinct publisher3 min readUpdated
Work-health measures peak at task-level use, at 75% healthy utilization, then fall about five points once AI is embedded in the workflow. Only 2% of tracked employees got that far.
The Investor · Invest desk
Compiled by The InvestorSomething wrong?How this is made
Work-health measures peak at task-level use, at 75% healthy utilization, then fall about five points once AI is embedded in the workflow. Only 2% of tracked employees got that far.
ActivTrak's Productivity Lab followed the same 120,620 employees across 1,009 organizations for three consecutive quarters, from Q4 2025 through Q2 2026, and reported that work-health and productivity measures climb as people move from little or no AI use to regular task-level use, then give the gain back once AI is embedded in the workflow [1][2][3]. Writing in Fortune, ActivTrak's chief executive says healthy utilization peaks at 75% at task-level adoption and falls about five percentage points at the deepest maturity stage, to a level the Lab describes as statistically indistinguishable from employees who barely use AI [4][3][5].
The distribution matters more than the curve. The Lab sorts behavioral data into three stages of maturity [21]: 27% of tracked employees used AI like a search engine to answer questions and summarize [6], 14% used it to draft content, generate ideas and complete routine tasks they then validated [7], and 2% reached workflow integration [8]. Users total 43% of the population studied [9], which leaves 57% outside the three stages entirely [10], and the stage counts add up exactly to the reported total [11]. So the cohort sitting at the far end of the maturity ladder is about one in fifty employees overall and roughly one in twenty-two AI users [12], on the order of 2,400 people at this study's headcount [13]. Their healthy utilization lands near 70% [14]. The stage the CEO argues most organizations should target is the middle one, illustrated by a sales rep generating a quote from five systems with a single prompt instead of compiling it by hand [23][16].
The cost anecdote is the most concrete thing in the column. ActivTrak's own operations team watched Anthropic spend rise, traced it to employees routinely using the newest and most powerful model to rewrite customer emails, and built an internal reference to match model to task [17]. That is a procurement failure, not a capability story, and it follows from how maturity is priced: deeper usage means more powerful models, more tokens, more infrastructure [18]. The second named risk is operational disconnect, where individuals assemble sophisticated workflows that optimize their own tasks without improving the broader process, producing what the CEO calls more AI slop, faster [19].
Note who is selling the remedy. The answer offered in both cases is more visibility into how AI changes work [20], and visibility built on behavioral data is what the Lab itself runs on [21]; the same column argues that license and login counts measure deployment rather than impact [15]. The critique of consumption metrics is fair. It also happens to describe the vendor's product.
Watch whether the five-point dip survives as Stage 3 grows past 2%. With roughly 2,400 people in that bucket [13], self-selection among the earliest deep adopters is at least as plausible as workflow integration causing the decline, and the published piece does not set out how healthy utilization is composed or report stage-level sample detail [24]. Watch whether token spend per head starts appearing next to seat counts in board packs, since model-to-task guidance was the fix ActivTrak reached for internally [17]. And watch for a replication outside a monitoring vendor's customer base: the sample averages about 120 tracked employees per organization [22], which is not the shape of the enterprise-wide rollout most AI strategies are written for.
Follow any of these and your For You feed starts watching them — no settings page required.
invest
The SEC just put a number on the pre-IPO grey market: 46% average markup, $74M, 800 buyers1 distinct publisher
build
Developer habit, priced at $965B: what Anthropic's run actually proves1 distinct publisher
invest
The two-year thesis: VCs are triaging portfolios, not reviewing them1 distinct publisher
invest
Stripe's reported $7B for OpenRouter buys the switchboard, not the models1 distinct publisher
Ranked by verification strength, evidence, and original report placement.
ActivTrak's Productivity Lab tracked the same 120,620 employees across 1,009 organizations for three consecutive quarters, from Q4 2025 to Q2 2026.
The column's example of Stage 2 is a sales rep generating a quote drawing on five systems with a single prompt instead of manually compiling the information.
The CEO argues the right level of AI maturity depends on the work being done and the business objectives it supports, and that Stage 2 is where healthy utilization peaks and where most organizations should focus.
The findings were published by Fortune on 16 August 2026 in a column authored by ActivTrak's CEO.
27% of employees studied used AI like a search engine to answer questions and summarize information, classified as Stage 1, Research Assistance.
14% of employees studied used AI to draft content, generate ideas and complete routine tasks that they then validate and finalize, classified as Stage 2, Task Execution.
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 16, 2026
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Large sample, single unaudited vendor account
The panel is unusually large and longitudinal (same 120,620 employees, 1,009 organizations, three quarters), which raises the ceiling, but every figure reaches the reader through one column written by the vendor's CEO. The healthy-utilization metric is never defined, no stage-level sample sizes or statistical tests accompany the 'statistically indistinguishable' claim, and no independent party has reviewed or replicated the data. The stage arithmetic checks out internally; the causal work-health finding cannot be verified from what is published.
Broad shallow AI use, deep integration at 2%
The disclosure itself measures workplace AI adoption at scale: 43% of tracked employees used AI, but only 14% at task level and 2% at workflow integration, with 57% outside any stage and 82% retention among adopters. So adoption of AI in the tracked population is real but shallow and concentrated. Adoption of the three-stage maturity framing and of the vendor's prescription is unmeasured — no other organization, standards body or publisher in the cluster is shown using it.
Counterintuitive headline outruns disclosed method
The framing that peak adoption is not peak work health rests on a roughly five-point movement in an undefined metric, self-reported by an interested vendor, with the low end drawn from a 2% subgroup whose sample size is never given — and the column itself concedes that endpoint is 'statistically indistinguishable' from near-non-use, which is as consistent with a flat relationship as with a peak. The overstatement is moderate rather than severe, because the column argues against maximal-adoption hype and reports its own inconvenient cost anecdote; the prescription that follows nonetheless routes to the vendor's product category.
Vendor CEO byline, remedy is the vendor's product
The author is ActivTrak's chief executive, the data comes from ActivTrak's own workforce-telemetry product, and the stated answer to both risks the column identifies is 'more visibility into how AI transforms work' — precisely what the company sells. The recommendation to target Stage 2 rather than maximal maturity also positions the vendor as the level-headed measurement layer between employers and AI spend. Nothing in the cluster discloses a competing interest or an external funder.
Directionally plausible, single-source and unfalsifiable as published
Confidence is limited by a one-publisher, one-author cluster with a strong commercial interest and no disclosed methodology, offset by an unusually large longitudinal panel, internally consistent arithmetic, and a specific self-implicating cost anecdote. The distribution figures and provenance are firm; the inverted-U work-health finding should be treated as an untested hypothesis until the metric, stage sample sizes and an independent read are available.